A detailed history of Barclays PLC transactions in Olink Holding Ab (Publ) stock. As of the latest transaction made, Barclays PLC holds 100 shares of OLK stock, worth $2,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$2,600
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

SELL
$14.29 - $25.95 $1,429 - $2,595
-100 Reduced 50.0%
100 $3,000
Q3 2023

Nov 07, 2023

BUY
$14.45 - $20.34 $1,445 - $2,034
100 Added 100.0%
200 $2,000
Q4 2022

Feb 13, 2023

SELL
$12.64 - $25.52 $222,046 - $448,309
-17,567 Reduced 99.43%
100 $3,000
Q3 2022

Nov 03, 2022

SELL
$12.14 - $18.42 $7.31 Million - $11.1 Million
-602,173 Reduced 97.15%
17,667 $214,000
Q2 2022

Aug 12, 2022

BUY
$8.95 - $19.24 $266,727 - $573,390
29,802 Added 5.05%
619,840 $9.42 Million
Q1 2022

May 16, 2022

BUY
$11.33 - $19.3 $6.69 Million - $11.4 Million
590,038 New
590,038 $10.4 Million

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Market Cap $3.1B
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.